Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Hansell

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
The American Journal of Surgical Pathology|November 16, 2011
Diffuse cystic lung disease of unexplained cause with coexistent small airway disease: a possible causal relationship?Camilla Rowan, David M Hansell, Elisabetta Renzoni, et al.
Radiology|December 11, 2012
Interobserver variability in the CT assessment of honeycombing in the lungsTakeyuki Watadani, Fumikazu Sakai, Takeshi Johkoh, et al.
Radiology|October 25, 2003
Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT featuresSusan J Copley, Athol U Wells, Pathanamathan Sivakumaran, et al.
Respirology (Carlton, Vic.)|February 12, 2009
Road ahead to respiratory health: experts chart future research directionsJohn E Heffner, Stephen T Holgate, Kian Fan Chung, et al.
American Journal of Respiratory and Critical Care Medicine|March 29, 2008
Interstitial lung disease in systemic sclerosis: a simple staging systemNicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
The Journal of Rheumatology|February 5, 2013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosisAngelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, et al.
The Lancet. Respiratory Medicine|November 21, 2017
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White PaperDavid A Lynch, Nicola Sverzellati, William D Travis, et al.
JCI Insight|June 9, 2016
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosisMark G Jones, Aurélie Fabre, Philipp Schneider, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
The American Journal of Surgical Pathology|November 16, 2011
Diffuse cystic lung disease of unexplained cause with coexistent small airway disease: a possible causal relationship?Camilla Rowan, David M Hansell, Elisabetta Renzoni, et al.
Radiology|December 11, 2012
Interobserver variability in the CT assessment of honeycombing in the lungsTakeyuki Watadani, Fumikazu Sakai, Takeshi Johkoh, et al.
Radiology|October 25, 2003
Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT featuresSusan J Copley, Athol U Wells, Pathanamathan Sivakumaran, et al.
Respirology (Carlton, Vic.)|February 12, 2009
Road ahead to respiratory health: experts chart future research directionsJohn E Heffner, Stephen T Holgate, Kian Fan Chung, et al.
American Journal of Respiratory and Critical Care Medicine|March 29, 2008
Interstitial lung disease in systemic sclerosis: a simple staging systemNicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
The Journal of Rheumatology|February 5, 2013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosisAngelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, et al.
The Lancet. Respiratory Medicine|November 21, 2017
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White PaperDavid A Lynch, Nicola Sverzellati, William D Travis, et al.
JCI Insight|June 9, 2016
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosisMark G Jones, Aurélie Fabre, Philipp Schneider, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
Pageof 17